Baseline characteristics of study populations
| Protocol 1 | Protocol 2 Patients n=10 | ||
|---|---|---|---|
| Patients n=20 | Healthy volunteers n=20 | ||
| Age | 61±9 | 22±4 | 69±9 |
| Female (%) | 15 (75) | 13 (65) | 3 (30) |
| Heart rate | 62±10 | 70±12 | 64±9 |
| Systolic blood pressure | 138±12 | 118±9 | 135±17 |
| Smoker (%) | 4 (20) | 0 (0) | 3 (30) |
| Coronary artery disease (%) | 18 (90) | 0 (0) | 7 (70) |
| Diabetes (%) | 4 (20) | 0 (0) | 2 (20) |
| Hypertension (%) | 15 (75) | 0 (0) | 90 (90) |
| Hyperlipidaemia | 15 (75) | 0 (0) | 70 (70) |
| Statin | 20 (100) | – | 9 (90) |
| Aspirin | 19 (95) | – | 10 (100) |
| β-Blocker | 12 (60) | – | 6 (60) |
| Nitrate | 6 (30) | – | 4 (40) |
| Calcium channel blocker | 8 (40) | – | 5 (50) |
| Baseline radial artery diameter (mm) | 2.7±0.4 | 2.7±0.4 | 2.8±0.5 |
N (%), mean±SD.